Sign in
Taking peopleNo phase

Home computer-based brain training for mild cognitive impairment or subjective cognitive decline

Tests RICORDO home brain training against an education program in older adults with memory concerns.

Key facts

Who runs it
Giovanna Zamboni
Where
Italy2 sites in 1 countryChoose a country to see its sites
Trial code
Registry title
Personalized Digital Training for COGnitive FITness in Mild Cognitive Impairment
Status
Recruiting
People taking part
100 people, planned
Started
28 Nov 2025
Expected to end
30 Nov 2026
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • RICORDO
  • S.A.M.B.A.
Record updated
29 April 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for people aged 50 or older with Mild Cognitive Impairment (MCI) or Subjective Cognitive Decline (SCD). They will do a 5-week home program, either digital brain training with RICORDO or an education program.

Age
50 years or older
Sex
All sexes
Disease stage
Mild Cognitive Impairment (MCI) or Subjective Cognitive Decline (SCD). MMSE score above 18 and CDR score of 1 or less.
Earlier treatment
Any medicine acting on the brain must have been stable for the past 3 months. People who took part in a cognitive or rehabilitation program in the last 3 months cannot join.

Main reasons for not taking part

  • Severe problems with senses or communication
  • Other brain disorders that may affect thinking, such as major stroke, brain tumor or brain injury
  • Major psychiatric disorders
  • Medical conditions that may affect thinking, such as kidney or liver failure, sleep apnea, low thyroid or vitamin B12 deficiency
  • Under legal guardianship, unable to understand and use written and spoken Italian, or 3 years of schooling or less

The registry criteria, word for word

Show all 14 criteriaShow less

Who can take part

  • Diagnosis of Mild Cognitive Impairment (MCI) based on Petersen (1999) and Winblad (2004), or Subjective Cognitive Decline (SCD) according to Jessen (2014)
  • Mini-Mental State Examination (MMSE) > 18 and Clinical Dementia Rating (CDR) ≤ 1
  • Age ≥ 50 years
  • Formal education > 3 years
  • Signed informed consent
  • Stable neurotropic pharmacological therapy in the past 3 months (if applicable)
  • Preserved mental capacity (i.e., not under legal guardianship or protective supervision)
  • Preserved ability to understand and produce written and spoken Italian

Who cannot take part

  • Failure to provide or withdrawal of informed consent
  • History or evidence of central nervous system disorders that may affect cognition and are unrelated to the study (e.g., major stroke, brain tumors, normal pressure hydrocephalus, traumatic brain injury)
  • History or evidence of major psychiatric disorders
  • Presence of medical conditions that may interfere with cognitive function (e.g., renal or hepatic failure, obstructive sleep apnea, hypothyroidism, vitamin B12 deficiency)
  • Severe sensory or communication impairments
  • Recent participation (< 3 months) in cognitive or rehabilitation programs

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The goal of this clinical trial is to determine whether a home-based digital cognitive-training program called RICORDO can enhance patients' ability to manage their own health and daily life when they have Mild Cognitive Impairment (MCI) or Subjective Cognitive Decline (SCD) and are 50 years of age or older.

Read full original descriptionShow less

The main questions it aims to answer are:

Does using RICORDO for five weeks raise the Patient Activation Measure (PAM) score more than an at-home paper-and-video education program called S.A.M.B.A.?

Does RICORDO also improve cognition, everyday functioning, quality of life and mood compared with S.A.M.B.A.?

Researchers will compare individuals who train with RICORDO to those who follow S.A.M.B.A. to determine which approach is more effective.

Participants will be randomly assigned to one of the two groups and complete three 45-minute sessions per week at home for five weeks. They will also visit the clinic at the beginning and end of the program to complete questionnaires and take brief thinking tests.

The 2 groups in the trial

  • RICORDO - Digital Cognitive RehabilitationTreatment being tested

    Participants assigned to this arm will receive a 5-week personalized cognitive training program using the CE-marked digital therapeutic RICORDO. The intervention consists of 15 tablet-based home sessions (3 per week, 45 minutes each), tailored to the participant's cognitive profile and performance, and remotely monitored by clinicians via a web platform.

    Treatment: RICORDO

  • S.A.M.B.A. - Lifestyle Education ProgramExisting treatment, for comparison

    Participants assigned to this arm will follow a 5-week home-based educational program called S.A.M.B.A., which includes 15 sessions (3 per week) using printed and video materials focused on socialization, healthy nutrition, physical activity, psychological well-being, and environmental stimulation. This arm is matched for contact time and format but does not include cognitive training.

    Treatment: S.A.M.B.A.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Personalized Digital Training for COGnitive FITness in Mild Cognitive Impairment: the COG-FIT Pragmatic Trial
Plain-language title
Home computer-based brain training for mild cognitive impairment or subjective cognitive declineGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 15 November 2026.
Record updated
29 April 2026